Loading…
Medicalgorithmics entered into a material agreement with a Canadian diagnostic services provider (subsidiary of a US-listed company) for the sale of at least 2,000 Kardiobeat.ai devices and AI software, valued at USD 5.9 million, with delivery by December 31, 2026.
“The Agreement covers the sale of Kardiobeat.ai devices, continuation of the lease of PocketECG devices, provision of specific services and licensing of the Company’s PocketECG PC Client software”medicalgorithmics.com
Summarized from public sources; check the original articles before acting on it.